the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Chinese Pharmaceutical Industry: Strategies, Trends and Opportunities

Published by Digital Vector, Inc. Contact us : +1-860-674-8796
Published 2005/08 Content info 360 PAGES - 16 Tables and Figures 23
Product code DV32277
Price From  US $ 6000 Order/Price list
US $ 6000 PDF by E-mail (Single User License)
US $ 24000 PDF by E-mail (Global Site License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

TABLE OF CONTENTS

INDUSTRY GROWTH

INDUSTRY GROWTH
PHARMACEUTICAL MARKET
POTENTIAL
DRIVERS OF CHINESE
PHARMACEUTICAL INDUSTRY
INDUSTRY CHARACTERISTICS
DOMESTIC INDUSTRY
DISEASE PROFILE
DRUGS WITH LARGEST MARKET
SCOPE
PRODUCT STRATEGIES

KEY TRENDS

INDUSTRY CHALLENGES
IMPACT OF WTO MEMBERSHIP
INDUSTRY CONSOLIDATION
ROLE OF GOVERNMENT
IMPORTS VS. EXPORTS
INCENTIVE STRUCTURES

INDUSTRY IN TRANSITION

REGULATIONS
R&D INVESTMENTS
R&D EXTERNALISATION
MANUFACTURING
DISTRIBUTION
EXPORTS
COLLABORATION WITH
MULTINATIONALS
ADVANTAGES FOR CHINESE ENTITIES
ADVANTAGES FOR MULTINATIONALS
MULTINATIONAL MANUFACTURING
FACILITIES
INTERACTIONS WITH US FDA
CHALLENGES
FUTURE OUTLOOK POST-REFORM

GOVERNMENT POLICIES

PHARMACEUTICAL PRICING POLICY
DRUG PRICING REFORMS PRICING OF DRUGS PROFIT MARGINS
MARKET LIBERALISATION REGULATORY FRAMEWORKS INCENTIVES
RATIONALISATION OF MARKET SFDA CLASSIFICATION

SOCIAL AND CULTURAL ISSUES

CHINESE BUSINESS NETWORKS NEGOTIATION
THE POLITICAL SYSTEM THE LEGAL SYSTEM
MACRO ECONOMIC ENVIRONMENT TECHNOLOGICAL ENVIRONMENT

BIOTECHNOLOGY INDUSTRY

GOVERNMENT ROLE RESEARCH INITIATIVES CHALLENGES

CHINESE HEALTHCARE SYSTEM

KEY TRENDS IN HEALTHCARE
MAJOR DISEASES
DISEASE PREVENTION MECHANISMS
PAST EXPERIENCES
HEALTH CARE DELIVERY NETWORK EVOLVING HEALTH CARE DELIVERY NETWORK
HEALTHCARE SYSTEM CHANGES STRUCTURE OF CHINA S HEALTHCARE SYSTEM
HEALTHCARE FINANCING
REGULATIONS
KEY PLAYERS IN THE CHINESE HEALTHCARE SYSTEM
HOSPITALS
STATE-OWNED HOSPITALS HOSPITAL FUNDING
FOREIGN INVESTORS IN CHINESE HEALTHCARE
JOINT VENTURES
LESSONS FROM THE PAST CHALLENGES FOR FOREIGN INVESTORS
POLICY RECOMMENDATIONS
RURAL HEALTHCARE
URBAN HEALTHCARE HEALTHCARE PERSONNEL GOVERNMENTAL PRIORITIES IN HEALTHCARE
HEALTHCARE REFORMS IN CHINA HEALTHCARE POLICY
RECOMMENDATIONS
HEALTHCARE FINANCING REFORMS
NATIONAL ESSENTIAL DRUG LIST (NEDL)
HEALTHCARE INSURANCE IN CHINA
CHARACTERISTICS
HEALTHCARE INSURANCE REFORMS

MEDICAL EQUIPMENTS AND DEVICES MARKET

TOP SELLING PRODUCT CATEGORIES MARKET DYNAMICS
MULTINATIONAL PRESENCE COMPETITION
KEY MARKET CHARACTERISTICS OPPORTUNITIES TO EXPLOIT MARKET REGULATORS AND THEIR ROLES
CHALLENGES
STRATEGIES FOR SUCCESS

CHINA S MEDICAL INSURANCE MARKET

IMPACT OF WTO
INSURANCE REGULATIONS IN CHINA LIBERALISATION OF INSURANCE INDUSTRY
DOMESTIC AND FOREIGN INSURANCE COMPANIES
RECOMMENDATIONS
POTENTIAL FOR INSURANCE MARKET IN CHINA
URBAN MEDICAL INSURANCE RURAL MARKET FOR MEDICAL INSURANCE
INDUSTRY CHALLENGES FUTURE DIRECTIONS

CHINA S DRUG PRICING REFORM AND DRUG PRICING POLICY

CHALLENGES IN THE CHINESE DRUG PRICING SYSTEM
CHINA S DRUG PRICING REFORMS FUTURE OF CHINA S DRUG PRICING REFORMS

CHINA S OTC DRUG MARKET

FOREIGN ENTRANTS REGIONAL VARIATIONS RETAIL MARKET
COSMETICS MARKET

CLINICAL TRIALS MARKET

CLINICAL TRIAL REQUIREMNETS FOR THE LOCAL MARKET
CLINICAL TRIAL REGULATIONS CLINICAL TRIALS AND CONTRACT RESEARCH ORGANIZATIONS IN CHINA BENEFITS FOR CHINESE INDUSTRY BENEFITS FOR FOREIGN PLAYERS CHALLENGES
RECOMMENDATIONS

PHARMACEUTICAL DISTRIBUTION IN CHINA

STATE CONTROL OF DISTRIBUTION CHANNELS

REGULATORY ISSUES FOR NEW DRUGS IN CHINA

HISTORY OF NEW DRUG REGULATION IN CHINA
CLASSIFICATION OF NEW DRUGS IN CHINA
DRUG REVIEW PROCESS
NEW DRUG REVIEW TIME
NEW DRUG MARKETING EXCLUSIVITY CLINICAL REQUIREMENTS
IMPORTED DRUGS
CLASS 1 NCE REGISTRATION

INTELLECTUAL PROPERTY PROTECTION ISSUES

INTELLECTUAL PROPERTY PROTECTION IN CHINA ADMINISTRATIVE PROTECTION CHANGING IP PROTECTION REGIME ADAPTATION OF CHINESE FIRMS

TRADITIONAL CHINESE MEDICINE

POPULARITY OF TRADITIONAL CHINESE MEDICINE (TCM) IN CHINA FORMS OF TCM
TCM DRIVING THE HEALTH FOOD INDUSTRY
POPULARITY OF TCM OUTSIDE OF CHINA
GLOBAL SCOPE FOR CHINESE TCM

FORECASTS FOR THE FUTURE

STRATEGIES FOR THE FUTURE

STRATEGIC OPTIONS FOR CHINESE FIRMS
GENERICS
TRADITIONAL MEDICINE NCEs RESEARCH
SUPPORT FOR NEW ENTERPRISES GOVERNMENT POLICIES

LIST OF TABLES

Table 1: Leading Chinese Provinces By Pharmaceutical Sales
Table 2: Drugs With Largest Market Scope
Table 3: Fastest Growing Therapeutic Categories
Table 4: Registration Procedure For Pharmaceutical Imports
Table 5: Foreign Invested Pharmaceutical Firms
Table 6: Collaboration Between Chinese Firms And Foreign Mncs
Table 7: Government-Set Profit Margins For Drug Types In China
Table 8: Death Rate Of Major Diseases In Urban Areas
Table 9: Death Rate Of Major Diseases In Rural
Table 10: Percentage Of Children Vaccinated For Various Diseases
Table 11: Foreign Insurance Companies In China
Table 12: Leading Pharmaceutical Categories In China s Retail Market
Table 13: Leading Imported Pharmaceutical Categories In China s Retail Market Table
14: Leading Pharmaceutical Manufacturers In China s Retail Market Table
15: Leading Pharmaceutical Products In China s Retail Market By Sales Table
16: Leading Pharmaceutical Categories In China s Retail Market By Volume

TABLE OF FIGURES

Figure 1: Size Of Chinese Pharmaceutical & Biotechnology Industry
Figure 2: Break-Up Of Chinese Pharmaceutical Firms Based On Ownership Structure
Figure 3: Break-Up Of Chinese Pharmaceutical Firms Based On Output
Figure 4: Break-Up Of Chinese Pharmaceutical Firms Based On Output
Figure 5: Break-Up Of China  s Drug Market Profile
Figure 6: Projected Break-Up Of China  s Drug Market Profile In 2010
Figure 7: Size Of China  s Pharmaceutical Exports
Figure 8: Chinese Political System
Figure 9: Number Of Biotechnology Companies In China
Figure 10: Sales Of Biotechnology Products In China
Figure 11: Biotechnology Patents Granted In China
Figure 12: Mapping Of The Chinese Government Network In Healthcare
Figure 13: Chinese Healthcare Expenditure
Figure 14: Healthcare Expenditure As A % Of Gnp
Figure 15: Chinese Healthcare Network
Figure 16: Size Of China  s Medical Equipment Market
Figure 17: Insurance Premium Growth In China
Figure 18: Density Of Life Insurance In China
Figure 19: Penetration Of Life Insurance In China
Figure 20: OTC Pharmaceutical Sales In China
Figure 21: Retail Pharmaceutical Outlets In China
Figure 22: China  s Otc Drug Distribution Pattern
Figure 23: China  Drug Distribution Network
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.